WO2006105741A3 - Topical pharmaceutical formulation containing nimesulide - Google Patents
Topical pharmaceutical formulation containing nimesulide Download PDFInfo
- Publication number
- WO2006105741A3 WO2006105741A3 PCT/CZ2006/000016 CZ2006000016W WO2006105741A3 WO 2006105741 A3 WO2006105741 A3 WO 2006105741A3 CZ 2006000016 W CZ2006000016 W CZ 2006000016W WO 2006105741 A3 WO2006105741 A3 WO 2006105741A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical formulation
- formulation containing
- topical pharmaceutical
- containing nimesulide
- nimesulide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06705758A EP1879565A2 (en) | 2005-04-06 | 2006-04-06 | Topical pharmaceutical formulation containing nimesulide |
EA200702171A EA200702171A1 (en) | 2005-04-06 | 2006-04-06 | PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING NIMESULIDE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZPV214-05 | 2005-04-06 | ||
CZ20050214A CZ2005214A3 (en) | 2005-04-06 | 2005-04-06 | Topical medicamentous form containing nimesulide |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2006105741A2 WO2006105741A2 (en) | 2006-10-12 |
WO2006105741A3 true WO2006105741A3 (en) | 2007-03-08 |
WO2006105741B1 WO2006105741B1 (en) | 2007-04-19 |
Family
ID=37073817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CZ2006/000016 WO2006105741A2 (en) | 2005-04-06 | 2006-04-06 | Topical pharmaceutical formulation containing nimesulide |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1879565A2 (en) |
CZ (1) | CZ2005214A3 (en) |
EA (1) | EA200702171A1 (en) |
WO (1) | WO2006105741A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110056516A (en) * | 2008-09-12 | 2011-05-30 | 크리티컬 파머수티컬스 리미티드 | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
KR102086316B1 (en) * | 2019-09-09 | 2020-03-09 | 한국콜마주식회사 | Cosmetic composition having excellent percutaneous absorption property |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0782855A1 (en) * | 1994-10-05 | 1997-07-09 | Helsinn Healthcare S.A. | Antiinflammatory agent for external use |
WO2000009117A1 (en) * | 1998-08-12 | 2000-02-24 | Edko Trading And Representation Company Limited | Nimesulide containing topical pharmaceutical compositions |
US6258816B1 (en) * | 1997-11-06 | 2001-07-10 | Panacea Biotec Limited | Anti-allergy anti-inflammatory composition |
WO2005087195A2 (en) * | 2004-03-18 | 2005-09-22 | Panacea Biotec Ltd. | Novel compositions for topical delivery |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2188007C2 (en) * | 1998-10-27 | 2002-08-27 | Панацея Биотек Лимитед | New antiallergic antiphlogistic composition and method for its obtaining |
-
2005
- 2005-04-06 CZ CZ20050214A patent/CZ2005214A3/en not_active IP Right Cessation
-
2006
- 2006-04-06 EP EP06705758A patent/EP1879565A2/en not_active Withdrawn
- 2006-04-06 EA EA200702171A patent/EA200702171A1/en unknown
- 2006-04-06 WO PCT/CZ2006/000016 patent/WO2006105741A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0782855A1 (en) * | 1994-10-05 | 1997-07-09 | Helsinn Healthcare S.A. | Antiinflammatory agent for external use |
US6258816B1 (en) * | 1997-11-06 | 2001-07-10 | Panacea Biotec Limited | Anti-allergy anti-inflammatory composition |
WO2000009117A1 (en) * | 1998-08-12 | 2000-02-24 | Edko Trading And Representation Company Limited | Nimesulide containing topical pharmaceutical compositions |
WO2005087195A2 (en) * | 2004-03-18 | 2005-09-22 | Panacea Biotec Ltd. | Novel compositions for topical delivery |
Also Published As
Publication number | Publication date |
---|---|
EP1879565A2 (en) | 2008-01-23 |
CZ297215B6 (en) | 2006-10-11 |
WO2006105741B1 (en) | 2007-04-19 |
EA200702171A1 (en) | 2008-04-28 |
WO2006105741A2 (en) | 2006-10-12 |
CZ2005214A3 (en) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0806531A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND. | |
DK1792927T3 (en) | New block copolymer, micelle preparation and anticancer agent containing the same as active ingredient | |
IL193274A0 (en) | Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant | |
WO2009072007A3 (en) | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof | |
WO2007100776A3 (en) | Antimicrobial compositions and methods for locking catheters | |
EP1589947B8 (en) | Pharmaceutical formulation with an insoluble active agent for pulmonary administration | |
RS51569B (en) | Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol | |
WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
BRPI0922435A2 (en) | "sirtuine modulatory thiazolopyridine compound, pharmaceutical composition comprising the same and its use." | |
PL1831240T3 (en) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same | |
WO2006138735A3 (en) | Gel compositions for topical administration | |
WO2006056696A3 (en) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
BRPI0619911A2 (en) | compound, prodrug, pharmaceutical agent, and compound use | |
IL195935A0 (en) | 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same | |
WO2008142569A3 (en) | Topical compositions containing magaldrate | |
IL192206A0 (en) | Topical mecamylamine formulations for ocular administration and uses thereof | |
WO2006072070A3 (en) | Pharmaceutical formulations of gallium salts | |
PL1795186T5 (en) | Flupirtin comprising medicament formulation with a controlled release of the active agent | |
WO2008003050A3 (en) | Gallium nitrate formulations | |
WO2007133944A3 (en) | Topical administration of acyclovir | |
IL179594A0 (en) | Ultrasound contrast agent dosage formulation | |
WO2010052466A8 (en) | Pharmaceutical aerosol composition | |
EP1584335A3 (en) | Active substance combination comprising a carbinol composition and an opioid | |
WO2007065625A3 (en) | Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulations | |
WO2006105741A3 (en) | Topical pharmaceutical formulation containing nimesulide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006705758 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200702171 Country of ref document: EA |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06705758 Country of ref document: EP Kind code of ref document: A2 |
|
WWP | Wipo information: published in national office |
Ref document number: 2006705758 Country of ref document: EP |